Hillman Capital Management, Inc. Amgen Inc Transaction History

Hillman Capital Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 04, 2020	SELL	$197.81 - $242.74 $1.76 Million - $2.16 Million	-8,888 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$182.24 - $241.7 $48,111 - $63,808	-264 Reduced 2.88%	8,888 $1.8 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $1.73 Million - $2.23 Million	9,152 New	9,152 $2.21 Million

3,054

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Hillman Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hillman Capital Management, Inc. with notifications on news.